Create Your
TGCT Plan

Jump to:

TGCT TreatmentNon-surgical OptionsYour TGCT Team
A woman who is trapped by her tgct. She is wrapped up in the tumor.

How is TENOSYNOVIAL GIANT CELL TUMOR (TGCT) treated?

TGCT is often treated with surgery. Doctors may also recommend an active surveillance approach to monitor disease progression.

Surgery isn’t right for everyone, and not all tumors can be removed. The risk of recurrence is high for people who have diffuse TGCT or have had recurrence after surgery.

Each additional surgery increases risks of complications and other health challenges.

Recurrence can cause people to get stuck in a cycle of surgeries that interrupts their lives, so it's important to consider the risks and benefits of each treatment when choosing a path forward.

DIFFUSE TGCT RECURRENCE RATE

up to

72

%

The good news?

You have more options beyond surgery.

Oral prescription options are available

  • Treatment choice icon

    The choice between surgery and prescription treatment is up to you and your doctor

  • Decision factors icon

    The decision can be made based on physical or non‑physical reasons

  • Not recommended icon

    Radiation is usually not recommended since there is limited evidence to support its usage

  • Active surveillance icon

    Active surveillance may be recommended for those without symptoms

When discussing your treatment options, ask your care team about:

  • Treatment effectiveness icon

    How well the treatment shrinks tumors, and improves symptoms like pain and stiffness

  • Joint mobility icon

    If the treatment improves joint mobility or ability for everyday tasks

  • Side effects icon

    Any side effects, and how the treatment fits into your daily life

  • Treatment choice icon

    The choice between surgery and prescription treatment is up to you and your doctor

  • Decision factors icon

    The decision can be made based on physical or non‑physical reasons

  • Not recommended icon

    Radiation is usually not recommended since there is limited evidence to support its usage

  • Active surveillance icon

    Active surveillance may be recommended for those without symptoms

  • Treatment effectiveness icon

    How well the treatment shrinks tumors, and improves symptoms like pain and stiffness

  • Joint mobility icon

    If the treatment improves joint mobility or ability for everyday tasks

  • Side effects icon

    Any side effects, and how the treatment fits into your daily life

BE YOUR OWN ADVOCATE FOR WHAT'S BEST FOR YOUR TGCT

Living with the burden of TGCT doesn't have to be your only option. Ask for a referral to a center with a multidisciplinary care team of oncologists, orthopedic oncologists, radiologists, physical therapists, and others that treat TGCT or similar diseases at the time of diagnosis. Then you can work with the team to help create an individualized care plan that's right for you.

Since TGCT is rare, not all doctors have encountered it—so it's important to speak with an oncologist or TGCT treater for guidance.

map of the 48 contiguous united states
SEE A list of TGCT treaters
Contact Us

Intended for US Audiences Only.

© 2025 Deciphera Pharmaceuticals, LLC. The following are registered trademarks of Deciphera Pharmaceuticals, LLC: DECIPHERA and Deciphera logo. All rights reserved. All logos and trademarks are the sole property of their respective owners.
DCPH‑P02546 08/25